Tananbaum James B.
Insider CIK 1581754 · AMBI 10% owner · AERI 10% owner · ACRS 10% owner · AIMT 10% owner · THRX 10% owner · TXG 10% owner · KNTE Director, 10% owner · QSI Director · FSDC President & CEO, Director, 10% owner · FSII President and CEO, Director, 10% owner · ALMS Director, 10% owner · LTGO Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 2,203,800 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | — | 3,414,544 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 2,203,800 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | — | 1,868,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | — | 1,125,823 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | — | 3,562,984 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | — | 3,117,664 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,123,337 | — | $0 | 1,123,337 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,176,470 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,123,337 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 680,486 | — | $0 | 680,486 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-01-08 | 2026-01-12 | 117,647 | $17.00 | $2.00M | 5,702,536 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-01-08 | 2026-01-12 | 294,117 | $17.00 | $5.00M | 2,908,332 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-21 | 2025-11-25 | 72,212 | $7.38 | $532.9K | 2,614,215 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-19 | 2025-11-19 | 190,500 | $6.56 | $1.25M | 2,542,003 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-18 | 2025-11-19 | 117,374 | $6.19 | $726.5K | 2,351,503 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-17 | 2025-11-19 | 50,000 | $5.60 | $280.0K | 2,084,129 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-17 | 2025-11-19 | 150,000 | $5.59 | $838.5K | 2,234,129 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-06 | 2025-05-06 | 20,000 | $4.34 | $86.8K | 4,247,670 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-02 | 2025-05-06 | 25,000 | $4.62 | $115.5K | 4,227,670 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 967,567 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 622,344 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,122,994 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 481,283 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,703,998 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,022,398 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 194,459 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,944,577 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 622,344 | — | $0 | 4,249,991 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,122,994 | — | $0 | 3,067,571 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2024-07-01 | 2024-07-03 | 2,187,500 | $16.00 | $35.00M | 4,202,670 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,703,998 | — | $0 | 2,015,170 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 311,172 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 1,960,337 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 1,278,739 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 967,567 | — | $0 | 967,567 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 2,034,129 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 1,352,531 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 1,041,359 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 481,283 | — | $0 | 481,283 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 194,459 | — | $0 | 194,459 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2024-07-01 | 2024-07-03 | 312,500 | $16.00 | $5.00M | 5,584,889 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,022,398 | — | $0 | 5,272,389 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,944,577 | — | $0 | 1,944,577 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 3,627,647 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 40,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 9,671,643 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 3,525,957 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 520,711 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 37,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 37,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 75,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | J Other | 2023-08-31 | 2023-08-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer | 2023-08-31 | 2023-08-31 | 16,813,146 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 523,450 | $2.97 | $1.55M | 4,108,796 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 176,550 | $2.97 | $524.4K | 1,385,825 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2023-06-01 | 2023-06-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 1,550,956 | $2.80 | $4.34M | 3,525,957 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 229,044 | $2.80 | $641.3K | 520,711 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2023-04-05 | 2023-04-06 | 773,952 | $1.50 | $1.16M | 13,583,762 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2023-04-05 | 2023-04-06 | 773,952 | $1.50 | $1.16M | 8,773,134 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | J Other | 2023-02-17 | 2023-02-22 | 1,100,000 | — | $0 | 1,975,001 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-29 | 2023-01-03 | 250,000 | $5.00 | $1.25M | 1,209,275 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-29 | 2023-01-03 | 250,000 | $5.00 | $1.25M | 3,585,346 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2022-12-01 | 2022-12-05 | 637,420 | $0.85 | $541.8K | 12,809,810 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2022-06-08 | 2022-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2021-12-23 | 2022-06-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-28 | 4,873,750 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2021-12-23 | 2021-12-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-30 | 4,941,250 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-28 | 4,873,750 | — | $0 | 4,873,750 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award | 2021-12-23 | 2021-12-28 | 1,000,000 | $10.00 | $10.00M | 1,000,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award | 2021-12-23 | 2021-12-28 | 7,759,072 | — | $0 | 7,759,072 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-30 | 4,941,250 | — | $0 | 4,941,250 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2021-12-22 | 2021-12-23 | 325,000 | $10.00 | $3.25M | 325,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2021-11-01 | 2021-11-03 | 8,276 | — | $0 | 8,276 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2021-11-01 | 2021-11-03 | 1,954,904 | — | $0 | 0 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-10-04 | 2021-10-06 | 17,245 | — | $0 | 17,245 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-11 | 2021-06-14 | 20,512 | — | $0 | 20,512 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 4,463,619 | — | $0 | 4,463,619 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 743,936 | — | $0 | 743,936 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 1,250,000 | $10.00 | $12.50M | 1,993,936 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 348,125 | — | $0 | 2,342,061 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 1,250,000 | $10.00 | $12.50M | 1,250,000 | SEC↗ |
| QSI Quantum-Si Inc | A Award | 2021-06-10 | 2021-06-14 | 348,125 | — | $0 | 1,598,125 | SEC↗ |
| FSII FS Development Corp. II | P Buy | 2021-02-19 | 2021-02-23 | 602,500 | $10.00 | $6.03M | 602,500 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | C Conversion deriv | 2021-02-05 | 2021-02-09 | 2,928,750 | — | $0 | 0 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | C Conversion | 2021-02-05 | 2021-02-09 | 2,928,750 | — | $0 | 2,928,750 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award | 2021-02-05 | 2021-02-09 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 6,347,893 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 99,488 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,666,002 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 55,922 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 18,641 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 157,222 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 145,128 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 48,376 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 298,465 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 166,667 | — | $0 | 291,667 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,171,643 | — | $0 | 9,671,643 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 500,001 | — | $0 | 875,001 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-03 | 2020-12-04 | 500,000 | $20.00 | $10.00M | 500,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-03 | 2020-12-04 | 375,000 | $20.00 | $7.50M | 375,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-03 | 2020-12-04 | 125,000 | $20.00 | $2.50M | 125,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2020-12-02 | 2020-12-04 | 40,501 | — | $0 | 40,501 | SEC↗ |
| FSDC FS Development Corp. | P Buy | 2020-08-14 | 2020-10-19 | 441,500 | $10.00 | $4.42M | 441,500 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-05-13 | 2020-05-14 | 650,000 | $80.13 | $52.08M | 2,350,000 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-05-13 | 2020-05-14 | 800,000 | $80.13 | $64.10M | 3,500,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-12 | 2020-05-14 | 1,930,198 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-12 | 2020-05-14 | 1,930,198 | — | $0 | 4,300,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-06 | 2020-05-08 | 500,000 | — | $0 | 1,930,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-05-06 | 2020-05-08 | 1,500,000 | — | $0 | 3,153,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-06 | 2020-05-08 | 1,500,000 | — | $0 | 3,000,000 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-05-06 | 2020-05-08 | 500,000 | — | $0 | 2,369,802 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-04-23 | 2020-04-24 | 1,000,000 | — | $0 | 2,430,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-04-23 | 2020-04-24 | 1,000,000 | — | $0 | 1,869,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 700,000 | — | $0 | 869,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 178,584 | — | $0 | 178,584 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 178,584 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-22 | 2020-04-24 | 92,258 | — | $0 | 327,383 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-04-14 | 2020-04-15 | 1,500,000 | — | $0 | 4,653,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-04-14 | 2020-04-15 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 109,849 | — | $0 | 235,125 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 788,317 | — | $0 | 1,569,802 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 21,686 | — | $0 | 21,686 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 21,686 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 201,115 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 201,115 | — | $0 | 201,115 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-04-13 | 2020-04-15 | 433,725 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-24 | 2020-03-26 | 2,170,619 | — | $0 | 3,430,198 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-24 | 2020-03-26 | 2,170,619 | — | $0 | 2,358,119 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 241,619 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 241,619 | — | $0 | 241,619 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 947,079 | — | $0 | 187,500 | SEC↗ |
| TXG 10x Genomics, Inc. | J Other | 2020-03-18 | 2020-03-19 | 125,276 | — | $0 | 125,276 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-03-17 | 2020-03-19 | 250,000 | $59.00 | $14.75M | 433,725 | SEC↗ |
| TXG 10x Genomics, Inc. | S Sale | 2020-03-17 | 2020-03-19 | 500,000 | $59.00 | $29.50M | 1,134,579 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-04 | 2020-03-19 | 1,447,079 | — | $0 | 5,600,817 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2020-03-04 | 2020-03-19 | 683,725 | — | $0 | 6,153,528 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-04 | 2020-03-19 | 1,447,079 | — | $0 | 1,634,579 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion | 2020-03-04 | 2020-03-19 | 683,725 | — | $0 | 683,725 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 271,767 | $17.07 | $4.64M | 1,229,633 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 302,776 | $17.07 | $5.17M | 1,369,938 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 425,457 | $17.07 | $7.26M | 1,925,020 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-12-20 | 2019-12-23 | 289 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-12-20 | 2019-12-23 | 28,900 | $30.00 | $867.0K | 1,501,400 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-12-03 | 2019-12-05 | 266 | — | $0 | 289 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-12-03 | 2019-12-05 | 26,600 | $30.00 | $798.0K | 1,472,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-26 | 2019-12-05 | 44 | — | $0 | 555 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-26 | 2019-12-05 | 4,400 | $30.00 | $132.0K | 1,445,900 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-15 | 2019-11-18 | 199 | — | $0 | 599 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-15 | 2019-11-18 | 19,900 | $30.00 | $597.0K | 1,441,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-14 | 2019-11-18 | 57 | — | $0 | 798 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-14 | 2019-11-18 | 5,700 | $30.00 | $171.0K | 1,421,600 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-07 | 2019-11-12 | 150 | — | $0 | 855 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-07 | 2019-11-12 | 15,000 | $30.00 | $450.0K | 1,415,900 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 1,324,195 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 5,513,058 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 6,837,253 | — | $0 | 6,837,253 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 1,002,166 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 5,487,470 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 7,047,896 | — | $0 | 7,047,896 | SEC↗ |
| TXG 10x Genomics, Inc. | C Conversion deriv | 2019-09-16 | 2019-09-16 | 558,260 | — | $0 | 0 | SEC↗ |
| TXG 10x Genomics, Inc. | P Buy | 2019-09-12 | 2019-09-16 | 187,500 | $39.00 | $7.31M | 187,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-05 | 2019-09-06 | 15,700 | $18.42 | $289.2K | 2,350,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-04 | 2019-09-06 | 9,300 | $18.48 | $171.9K | 2,334,777 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-04 | 2019-09-06 | 90,900 | $18.48 | $1.68M | 1,400,900 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-04 | 15,100 | $21.45 | $323.9K | 2,325,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-04 | 34,900 | $20.54 | $716.8K | 2,310,377 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-30 | 2019-09-04 | 25,000 | $21.36 | $534.0K | 2,275,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-23 | 2019-08-23 | 38,300 | $23.42 | $897.0K | 2,250,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-22 | 2019-08-23 | 6,700 | $23.68 | $158.7K | 2,212,177 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-21 | 2019-08-23 | 1,153 | $23.25 | $26.8K | 2,205,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-20 | 2019-08-20 | 50,000 | $23.21 | $1.16M | 2,204,324 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-19 | 2019-08-20 | 3,847 | $23.34 | $89.8K | 2,154,324 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-16 | 2019-08-20 | 100,000 | $24.23 | $2.42M | 2,150,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-14 | 2019-08-14 | 100,000 | $23.73 | $2.37M | 2,050,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-13 | 2019-08-14 | 71,097 | $24.92 | $1.77M | 1,131,097 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-13 | 2019-08-14 | 178,903 | $25.52 | $4.57M | 1,310,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-12 | 2019-08-14 | 189,555 | $24.43 | $4.63M | 1,060,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2017-05-26 | 2017-05-31 | 9,818 | $55.95 | $549.3K | 1,672,714 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2017-05-26 | 2017-05-31 | 10,182 | $55.95 | $569.7K | 1,950,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2016-10-06 | 2016-10-07 | 24,813 | $40.34 | $1.00M | 1,647,901 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2016-10-06 | 2016-10-07 | 25,187 | $40.34 | $1.02M | 1,672,697 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2016-10-06 | 2016-10-11 | 24,813 | $40.34 | $1.00M | 1,647,901 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2016-10-06 | 2016-10-11 | 25,187 | $40.34 | $1.02M | 1,672,697 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2016-07-22 | 2016-07-26 | 250,000 | $17.50 | $4.38M | 1,697,884 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2016-05-31 | 2016-06-02 | 120,000 | $15.23 | $1.83M | 235,020 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2016-05-31 | 2016-06-02 | 120,000 | $15.23 | $1.83M | 3,967,900 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-24 | 2015-08-26 | 25,485 | $19.65 | $500.8K | 355,020 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion deriv | 2015-08-11 | 2015-08-11 | 3,775,400 | — | $0 | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion | 2015-08-11 | 2015-08-11 | 3,775,400 | — | $0 | 3,775,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 17,035 | $20.50 | $349.2K | 329,535 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 312,500 | $16.00 | $5.00M | 312,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 312,500 | $16.00 | $5.00M | 4,087,900 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-24 | 2013-10-16 | 4,817 | $6.77 | $32.6K | 2,079,569 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-14 | 2013-10-16 | 7,500 | $7.46 | $56.0K | 2,074,752 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-12 | 2013-10-16 | 5,700 | $7.45 | $42.5K | 2,067,252 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-06-03 | 2013-10-16 | 10,000 | $6.99 | $69.9K | 2,061,552 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-22 | 2013-10-16 | 5,005 | $6.74 | $33.7K | 2,051,552 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-21 | 2013-10-16 | 1,811 | $6.84 | $12.4K | 2,046,547 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-20 | 2013-10-16 | 8,120 | $6.90 | $56.0K | 2,044,736 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | P Buy | 2013-05-17 | 2013-10-16 | 36,616 | $6.77 | $247.9K | 2,036,616 | SEC↗ |